Literature DB >> 10919269

Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene.

I M Byrne1, L Flanagan, M P Tenniswood, J Welsh.   

Abstract

To gain insight into the molecular regulation of the human vitamin D3 receptor (hVDR), we have cloned and sequenced the 5' flanking region of exon 1c and examined promoter activity of this region in breast cancer cells. Sequence analysis of the first 1300 bp upstream of exon 1c reveals several characteristics of a class II promoter, including GC-rich regions and the presence of a TATA box at -29 bp. Putative transcription factor binding sites identified in this potential hVDR promoter include AP-2, Sp-1, and glucocorticoid response elements. No consensus vitamin D3 (VDRE) or estrogen (ERE) responsive elements were identified in the promoter sequence. Primer extension analysis performed with a primer specific for exon 1c confirms that transcription initiated in the 5' flanking region of exon 1c occurs in MCF-7 cells. Transient transfection of MCF-7 cells with this putative promoter region cloned into the pRLnull luciferase reporter vector generates significant reporter gene activity that is enhanced by treatment with forskolin, retinoic acid, and 17beta-estradiol. The enhancement of exon 1c promoter activity by 17beta-estradiol is blocked by the selective estrogen response modifier (SERM) tamoxifen and is not observed in estrogen receptor-negative breast cancer cells. In summary, we have cloned and characterized a TATA containing promoter upstream of exon 1c of the hVDR and provide evidence that this region represents a hormonally regulated hVDR promoter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919269     DOI: 10.1210/endo.141.8.7618

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer.

Authors:  Erin L Milliken; Xiaoxue Zhang; Chris Flask; Jeffrey L Duerk; Paul N MacDonald; Ruth A Keri
Journal:  Cancer Lett       Date:  2005-08-22       Impact factor: 8.679

2.  Glucocorticoid regulation of the vitamin D receptor.

Authors:  Alejandro A Hidalgo; Donald L Trump; Candace S Johnson
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-14       Impact factor: 4.292

3.  BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.

Authors:  Stefano Palomba; Francesco Orio; Tiziana Russo; Angela Falbo; Achille Tolino; Francesco Manguso; Vincenzo Nunziata; Pasquale Mastrantonio; Gaetano Lombardi; Fulvio Zullo
Journal:  Osteoporos Int       Date:  2005-03-01       Impact factor: 4.507

4.  Bone mass pharmacogenetics and ethnic health implications.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

Review 5.  Function of the vitamin D endocrine system in mammary gland and breast cancer.

Authors:  JoEllen Welsh
Journal:  Mol Cell Endocrinol       Date:  2017-06-01       Impact factor: 4.102

6.  Contribution of GPR30 for 1,25 dihydroxyvitamin D₃ protection in EAE.

Authors:  Sandhya Subramanian; Lisa M Miller; Marjorie R Grafe; Arthur A Vandenbark; Halina Offner
Journal:  Metab Brain Dis       Date:  2011-10-13       Impact factor: 3.584

Review 7.  Pubertal mammary gland development: insights from mouse models.

Authors:  Jillian Howlin; Jean McBryan; Finian Martin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

8.  In vivo profiling of estrogen receptor/specificity protein-dependent transactivation.

Authors:  Fei Wu; Rui Xu; Kyounghyun Kim; James Martin; Stephen Safe
Journal:  Endocrinology       Date:  2008-07-17       Impact factor: 4.736

Review 9.  Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Authors:  Stephen Safe; Kyounghyun Kim; Kyoungkim Kim
Journal:  J Mol Endocrinol       Date:  2008-09-04       Impact factor: 5.098

10.  Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.

Authors:  Kevin D Healy; Julia B Zella; Jean M Prahl; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.